产品编号：A794752
产品规格：5mg
产品价格：面议
| 标准品编号: | A794752 |
| 名称: | Auranofin-13C6 |
| 别名: | [1-(Thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold-13C6; 2,3,4,6-Tetraacetate(1-thio-β-D-glucopyranosato)(triethylphosphine)-gold-13C6; 1-Thio-β-D-glucopyranose 2,3,4,6-Tetraacetate Gold Complex; Aktil-13C6; Auranofin-13C6; Crisinor-13C6; Crisofin-13C6; NSC 32152-13C6; Ridaura-13C6; Ridauran-13C6; SKF 39162-13C6; SKF 39162D-13C6; [(Tetra-O-acetyl-β-D-glucopyranosyl)thio](triethylphosphine)gold-13C6; |
| 备用CAS: | 未标记: 34031-32-8 |
| 分子式: | C₁₄¹³C₆H₃₄AuO₉PS |
| 分子量: | 684.44 |
| 类别: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides; |
| 应用: | Auranofin-13C6 is a labelled analogue of Auranofin (A794750), a new oral gold-based antiarthritis drug. Auranofin inhibits various leukocyte activation pathways at multiple sites. Auranofin inhibits the release of inflammatory mediators from human macrophages, basophils, and pulmonary mast cells. Auranofin is an efficient inducer of mitochondrial membrane permeability transition pore in the presence of calcium ions related to its inhibition of mitochondrial thioredoxin reductase. |
| 危险品信息: | Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
| 文献 | |
